Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      Deliberate Covid-19 infection trial finds symptoms don't indicate viral shedding
      Malaysiakini
      World
      Deliberate Covid-19 infection trial finds symptoms don't indicate viral shedding

      Deliberate Covid-19 infection trial finds symptoms don't indicate viral shedding

      Published: Apr 1, 2022 10:00 AM

      The world's first "human challenge" trial in which volunteers were deliberately exposed to the coronavirus has found that symptoms had no effect on how likely an infected person is to pass the disease on to others.

      The findings underscore the difficulty in preventing community infections as the Word Health Organization (WHO) warns of a rise in cases.

      The research project...

      Governments want Covid vaccine developers to aim higher in hunt for better shots

      Governments want Covid vaccine developers to aim higher in hunt for better shots

      BioNTech to expand trial programme for more anti-Omicron vaccine options

      BioNTech to expand trial programme for more anti-Omicron vaccine options

      Pfizer/BioNTech Covid-19 vaccine slashes children hospitalisation risk - US study

      Pfizer/BioNTech Covid-19 vaccine slashes children hospitalisation risk - US study

      Covid-19 (March 31): 18,560 new cases, 10k in S'gor alone

      Covid-19 (March 31): 18,560 new cases, 10k in S'gor alone

      WHO lays out plan to emerge from emergency phase of pandemic

      WHO lays out plan to emerge from emergency phase of pandemic

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports5

      Governments want Covid vaccine developers to aim higher in hunt for better shots

      01-04-2022

      BioNTech to expand trial programme for more anti-Omicron vaccine options

      31-03-2022

      Pfizer/BioNTech Covid-19 vaccine slashes children hospitalisation risk - US study

      31-03-2022

      Covid-19 (March 31): 18,560 new cases, 10k in S'gor alone

      01-04-2022

      WHO lays out plan to emerge from emergency phase of pandemic

      31-03-2022
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor